POMPANO BEACH, Fla.--(BUSINESS WIRE)--Stimwave Technologies, the leading innovator of wireless medical device bioelectronic technology, in honor of September Pain Awareness Month, today announces the launch of a new randomized clinical trial treating painful peripheral neuropathy, the “SMOOTH” study. Painful peripheral neuropathy resulting from damage to the peripheral nervous system affects an estimated 20 million people in the United States alone according the CDC. Nerve stimulation is a well
IRVINE, Calif.--(BUSINESS WIRE)--Dignity Health, MedStar Health and UPMC have earned 5-Star Awards for their commitments to PSMF APSS to eliminate preventable patient deaths.
NEWPORT BEACH, Calif.--(BUSINESS WIRE)-- #cureduchenne--CureDuchenne Announces Line-Up of 2020 Educational Events for Duchenne Community
ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (NYSE: IVC) today announced the appointment of Julie Beck to its Board of Directors, effective September 18, 2019. Ms. Beck currently serves as senior vice president and chief financial officer for NOVA Chemicals Corporation, a petrochemical company, a position she has held since 2016. Ms. Beck has more than 30 years of experience in the manufacturing, industrial and consumer industries, and is a certified public accountant. Ms. Beck was unani
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care announces publication of real-world data from more than 8,000 users of the t:slim X2 insulin pump with Basal-IQ technology.
AUSTIN, Texas--(BUSINESS WIRE)--Savara to Present Comprehensive Data From Pivotal Phase 3 IMPALA Study at 2019 ERS
SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent announces dividend
CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $VBIV--VBI Vaccines Inc. (Nasdaq: VBIV) (VBI or the Company), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced that it has commenced an underwritten public offering of its common shares. VBI also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of common shares offered in the public offering. The offering is subject to market and
PARIS & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Regulatory News: NANOBIOTIX (Paris:NANO): “The patient population in this study has significant unmet needs primarily due to pre-existing issues with hepatic function. When you combine that with the fact that there is low life expectancy for this group, you have a critical need for innovative treatment solutions. These data provide promising evidence that NBTXR3 activated by SBRT could be a valuable option with excellent safety and increased efficacy,
SAN CARLOS, Calif.--(BUSINESS WIRE)--CleanCision (TM), novel irrigating wound protection therapy shown to reduce high rates of SSI by 100% as compared to a standard wound protector.
AUSTIN, Texas--(BUSINESS WIRE)--CDISC releases first global Therapeutic Area Standard using Traditional Chinese Medicine.
WASHINGTON--(BUSINESS WIRE)--Susan G. Komen® today unveiled the Susan G. Komen® Center for Public Policy, which fights for the interests of those impacted by breast cancer.
WASHINGTON--(BUSINESS WIRE)--OS Therapies today announced the appointment of Robert Petit, Ph.D., as its Chief Medical and Scientific Advisor.
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--GrAI Matter Labs (aka GML), a neuromorphic computing pioneer today revealed NeuronFlow – a new programmable processor technology - and announced an early access program to its GrAIFlow software development kit. GML’s NeuronFlow technology draws from neuromorphic and dataflow paradigms to uniquely solve core problems for real world AI applications. One of the breakthroughs of the technology is dynamic dataflow processing of real-time data, which drasticall
WASHINGTON, D.C.--(BUSINESS WIRE)--Stericycle is the exclusive launch partner for the new National Safety Council Employer Toolkit that employers can use to address the opioid crisis.
CRANBURY, N.J.--(BUSINESS WIRE)-- #Immunotherapy--Pharmacy Times Continuing Education™ (PTCE), a leader in continuing education for retail, health-system, managed care, oncology and specialty pharmacists, will host the third of its 2019 Directions in Oncology Pharmacy™ fall conference series on Saturday, Oct. 19, at the Wyndham Grand Orlando Resort Bonnet Creek Hotel, in Orlando, Florida. This one-day pharmacy conference will provide live practical education to pharmacists in the inpatient, ambulatory, infusion
PARIS--(BUSINESS WIRE)--Regulatory News: Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO - FR0010095596), (“Onxeo” or “the Company”), a clinical-stage biotechnology company specializing in the development of innovative drugs targeting tumor DNA Damage response (DDR) in oncology, in particular against rare or resistant cancers, today announced positive results from the first group of patients in the DRIIV 1b study, evaluating AsiDNA™, first-in-class inhibitor of tumor DNA repair, in combina
SKOKIE, Illinois & RAVENSBURG, Germany--(BUSINESS WIRE)--Vetter announced that its US clinical manufacturing site located in Skokie has been named as one of Chicago’s Best and Brightest Companies to Work for
NEW YORK--(BUSINESS WIRE)--Analyst Hub, LLC, an independent research infrastructure platform company that provides talented sell-side analysts a path to owning their own enterprises, and R5 Capital, a boutique consumer-centric equity research and consulting firm focused on utilizing proprietary data and significant “boots on the ground” analysis to identify unique investment opportunities and provide strategic advice for companies, today announced their partnership with the launch of R5 Capital
OAKLAND, Calif.--(BUSINESS WIRE)-- #beverages--Nanogen, an innovative cannabis technology company for infused products, is rebranding under a new name, Vertosa, and adding five new talented hires.
NEW YORK--(BUSINESS WIRE)--Praesidian Capital Acquires Genetics Business
WOONSOCKET, R.I. & TORONTO--(BUSINESS WIRE)---- $ABAHF #AbacusHealthProducts--Abacus Health Products to participate in upcoming financial industry conferences to be held in Toronto and New York City.
LONDON--(BUSINESS WIRE)-- #CompetitiveIntelligence--Infiniti Research has announced the completion of their latest article on IoT in pharmaceutical manufacturing: how it will make a difference.
NEW YORK--(BUSINESS WIRE)--DeepIntent introduces MarketMatch™ for Advertisers, the first end-to-end programmatic advertising solution for healthcare and pharmaceutical brands.
CRANBURY, N.J.--(BUSINESS WIRE)-- #Cancer--OncLive®, the nation’s leading multimedia resource focused on providing oncology professionals with the most current and insightful information they need to offer the best patient care, will host its latest State of the Science Summit™ on Non-Small Cell Lung Cancer (NSCLC) on Thursday, Sept. 26, from 5-9 p.m. at the Omni William Penn Hotel, in Pittsburgh, Pennsylvania. The chair for the summit will be Antoinette Wozniak, M.D., FACP, FASCO, medical oncologist, as
CAMBRIDGE, Mass.--(BUSINESS WIRE)--bluebird bio presents updated data from Phase 2/3 clinical study of Lenti-D Gene Therapy for CALD at the 13th Annual EPNS Congress.
PISCATAWAY, N.J.--(BUSINESS WIRE)-- #CO2--Rocky Mountain Inst. CEO Jules Kortenhorst joins Board of Solidia whose tech reduces footprint of cement & concrete 70%, at least 1.5 GT CO2 each yr.
MORRISVILLE, N.C.--(BUSINESS WIRE)--Worldwide Clinical Trials announces that Aman Khera joined the company’s Scientific Solutions team as global head of regulatory strategy.
NEWBURY PARK, Calif.--(BUSINESS WIRE)--Compulink launches e-commerce solution for its all-in-one Optometry EHR at Vision Expo West.
AUSTIN, Texas--(BUSINESS WIRE)--Apollo Endosurgery Receives 510(k) Clearance for Polypropylene Suture-Anchor Assembly
IRVINE, Calif.--(BUSINESS WIRE)-- #TCT2019--TherOx announces key data presentations and company-sponsored events for SuperSaturated Oxygen (SSO2) Therapy at the upcoming TCT 2019 meeting.
BOULDER, Colo.--(BUSINESS WIRE)--Positive results from multiple studies support clinical utility of VeriStrat testing in advanced NSCLC and immunotherapy.
ORANGE, Calif.--(BUSINESS WIRE)--Alignment Healthcare, a Medicare Advantage insurance provider, announced today that it has added PIH Health, a nonprofit health care system that serves 2.5 million residents in Los Angeles and Orange counties, to its provider network. “PIH Health has been a cornerstone in Southeastern Los Angeles County and Northern Orange County, providing some of the most advanced care available anywhere to keep our communities healthy,” said James R. West, PIH Health presiden
SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- #AI--Aural Analytics selected to chair Voice Session at the 10th Annual CNS Summit, which will focus on the use of vocal biomarkers in clinical trials.
ALPHARETTA, Ga.--(BUSINESS WIRE)--Velan Capital, L.P. (together with the other members of its group, “Velan” or “we”), one of the largest stockholders of Progenics Pharmaceuticals, Inc. (“Progenics” or the “Company”)(NASDAQ:PGNX), comprised of successful specialty pharmaceutical operators and financial services experts, today announced that it has filed a preliminary consent statement with the SEC and delivered a written consent to the Company seeking to reconstitute the Progenics Board of Dire
HERZLIYA, Israel & BOSTON--(BUSINESS WIRE)--Prilenia’s Pridopidine Chosen to Participate in the First ALS Platform Trial by Led by the Sean M. Healey & AMG Center for ALS at Mass General
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Graybug Vision Initiates Clinical Trial in Macular Edema Secondary to Diabetic Macular Edema or Retinal Vein Occlusion
--(BUSINESS WIRE)--NorthStar Medical Radioisotopes to Host Ribbon-cutting, Groundbreaking and Speaker Event on Sept. 19, 2019 in Beloit, Wis.
DUBLIN--(BUSINESS WIRE)--The "United States Asthma Spacers Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering. The country research report on United States asthma spacers market is a customer intelligence and competitive study of the United States market. Moreover, the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the United States market. Also, factors that
CAMBRIDGE, Mass.--(BUSINESS WIRE)--X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the treatment of rare diseases, today announced the appointment of Renato Skerlj, Ph.D., as Senior Vice President, Research and Development. Dr. Skerlj has twenty-five years of experience leading the discovery and development of small molecule drugs to treat rare diseases, cancer, infection and neurodegenerative diseases. In
BEDFORD, Mass.--(BUSINESS WIRE)--Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic medicines company leveraging its proprietary hyaluronic acid ("HA") technology platform to provide therapies across the Joint Preservation and Restoration continuum of care, today announced it has commenced the U.S. commercial soft launch of TACTOSET, its injectable HA-enhanced bone repair therapy. TACTOSET has been developed for the treatment of bone voids and other bone defects of the ske
SOUTH SAN FRANCISCO--(BUSINESS WIRE)--insitro, a machine-learning driven drug discovery and development company, today announced key appointments to the company’s leadership team. Matthew Rasmussen, Ph.D. has been appointed as vice president of data engineering, and Duane Valz, J.D. has joined as general counsel. “At insitro, we are working to advance better therapies via predictive models, enabled by the convergence of cutting-edge machine learning and data generation at scale,” said Daphne Ko
ST. LOUIS--(BUSINESS WIRE)-- #3dprinting--CoreLink introduces low-profile solution for lateral lumbar plating, featuring the ability to optionally connect to CoreLink lateral interbodies.
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein's Practice Pink program has raised more than $1.6M for cancer research, prevention, and awareness efforts.
AUSTIN, Texas & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genprex's Chairman and CEO, Rodney Varner, will lead the company's webcast presentation on September 19, 2019.
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE:IQV) is proud to announce its collaboration with Friends of Cancer Research in a cross-industry effort to advance acceptance and drive future uses of real world evidence (RWE). This research helps confirm that clinical benefits seen for therapies in clinical trials were consistent with the benefits of those treatments within real world settings. RWE comprises dynamic data including assets such as EMR, hospital, pharmac
CHANDLER, Ariz.--(BUSINESS WIRE)-- #AZBW--Martha A. Brumfield, PhD, of the Critical Path Institute, will be honored as the Arizona Bioscience Leader of the Year at the 2019 AZBio Awards.
SAN DIEGO--(BUSINESS WIRE)--Progenity, Inc., a privately held biotechnology company, has acquired assets of ingestible device company Medimetrics GmbH. This acquisition further strengthens Progenity’s existing intellectual property portfolio and positions the company at the forefront of developing ingestible devices designed to advance research, diagnosis, and treatment for conditions of the gastrointestinal (GI) tract. “With the acquisition of Medimetrics’ assets, Progenity now holds one of th
SALT LAKE CITY--(BUSINESS WIRE)--PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced that it will present at the 2019 Cantor Global Healthcare Conference on Wednesday, October 2, 2019 in New York, NY. A live audio webcast of the 2019 Cantor Global Healthcare Conference presentation on October 2, 2019 at 3:00pm ET will be accessible in real time on the "News/Events" section of PolarityTE's Investor
BLOOMFIELD, Conn.--(BUSINESS WIRE)--Global health service company Cigna is expanding its individual health care exchange offerings to new geographies for 2020, with health plans now available in 19 markets across 10 states. This includes expansion into select counties in Kansas, South Florida and Utah as well as new counties in Tennessee and Virginia. Cigna's plans on the individual health care exchanges will include a number of features that provide access to quality health care and encourage
CLERMONT, Fla.--(BUSINESS WIRE)--Tom Donaldson, President, announced that Signet executed an Option to license all rights to medical non-invasive system to detect melanoma skin cancer using a vapor analysis system. The breakthrough operates in real time eliminating the time delay in diagnosis. The recently filed patent is also globally protected (PCT). “It’s exciting to avail this technology to the medical industry. It will be profitable to Signet shareholders. As a sufferer of this disease, I
ANN ARBOR, Mich.--(BUSINESS WIRE)---- $KBLB #KBLB--Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announces today that it has selected Mr. Anurag Gupta for its expanded Board of Directors. Among the many significant accomplishments during his career, Mr. Gupta has served as: the CEO of Global Data Services for TBG, the President for Europe, Middle East, and Africa region for BrightPoint, Inc, and the Executive Vice President of the CMS Division a
BOSTON & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ra Pharmaceuticals, Inc. (Nasdaq:RARX) today announced the selection of zilucoplan as one of the first clinical candidates to be evaluated in a pioneering platform trial for amyotrophic lateral sclerosis (ALS), led by the Sean M. Healey & AMG Center for ALS at Mass General. The Healey Center has agreed to provide funding for the execution of the platform trial to support its goal of accelerating the development of effective treatments for patients
IRVINE, Calif.--(BUSINESS WIRE)-- #Believeinbetter--Kinston Community Health Center Used NextGen Healthcare's NextGen Care Solution to prepare patients ahead of Hurricane Dorian's Landfall.
ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it will present data at the International Congress of Parkinson’s Disease and Movement Disorders, taking place September 22-26, 2019 in Nice, France. The data include two posters, which will be presented on Tuesday, September 24, 2019 from 1:45 PM to 3:15 PM CEST: Dyskinesia Rates in Patients with Parkinson’s Disease on CVT-301 (levodopa inhalation powder)(Abstract #1035) Impact of OFF periods on aspec
LYON, France--(BUSINESS WIRE)--POXEL S.A. (Euronext – POXEL – FR0012432516), a biopharmaceutical company dedicated to the development of innovative treatments for metabolic disorders, including type 2 diabetes and non-alcoholic steatohepatitis (NASH), announced today the presentation of detailed Phase 3 results from the TIMES 1 program, which evaluated the efficacy, safety and tolerability of Imeglimin in Japanese patients with type 2 diabetes as well as data supporting the safety and efficacy
HOUSTON--(BUSINESS WIRE)-- #EarlyBird--Saranas launches Early Bird, the first and only device for real-time detection and monitoring of endovascular bleed complications.
DUBLIN--(BUSINESS WIRE)--The "United States Wearable Injectors Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering. The country research report on the United States wearable injectors market is a customer intelligence and competitive study of the United States market. Moreover, the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the United States market. Also,
WALTHAM, Mass.,--(BUSINESS WIRE)--CVRS to host breakfast symposium and hands-on demos at TCT 2019 to highlight remote and automated capabilities of its CorPath GRX technology.
DUBLIN--(BUSINESS WIRE)--The "United States Endoscopy Ultrasound Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering. The country research report on United States endoscopy ultrasound market is a customer intelligence and competitive study of the United States market. Moreover, the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the United States market. Also,
JEFFERSONVILLE, Ind.--(BUSINESS WIRE)-- #HemostasisValve--Next generation design options for medical device companies looking to accelerate time to market. On display next week at TCT 2019 conference.
MIAMI & DONAUESCHINGEN, Germany--(BUSINESS WIRE)-- #FirstAndOnly--Biedermann Motech to introduce MOSS VRS® - The Next Generation Pedicle Screw Technology™ to the US market at NASS 2019 in Chicago.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a GI healthcare company, announced today that it has amended its collaboration agreement with AstraZeneca for the development and commercialization of LINZESS in China. LINZESS was approved by the National Medical Products Administration for adults with IBS-C in China in January 2019. LINZESS is expected to be launched in China in the second half of 2019. Under the terms of the amended agreement, AstraZeneca will
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to Gazyva® (obinutuzumab) for adults with lupus nephritis. This designation was granted based on data from the Phase II NOBILITY study in adult patients with proliferative lupus nephritis which showed Gazyva, in combination with standard of care (mycophenolate mofetil
SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system (CNS) disorders, today announced the pricing of an underwritten public offering of 6,250,000 shares of its common stock, offered at a price to the public of $40.00 per share. The gross proceeds from this offering to ACADIA are expected to be approximately $250 million,
TOKYO--(BUSINESS WIRE)--Shiseido has agreed on Sept. 17, 2019 to extend for a further six years its research alliance with the dermatological laboratory CBRC in Boston.
HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences Grants Equity Incentive Awards to New Employees
LONG BEACH, Calif.--(BUSINESS WIRE)--Sunstone Management and the City of Long Beach’s Economic Development Department have partnered with the Southern California Biomedical Council (SoCalBio) to kick-off its 21st Annual Conference with a CEO/Investor Reception and Dinner on September 18 at the Westin Hotel in Long Beach, CA. SoCalBio, the trade association for the bioscience and digital health industries in the Greater Los Angeles region, presents its key annual event to showcase Southern Calif
KENILWORTH, N.J., & WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)---- $MRK #MRK--FDA Approves KEYTRUDA® (pembrolizumab) plus LENVIMA® (lenvatinib) Combination Treatment for Patients with Certain Types of Endometrial Carcinoma